Llama antibodies could provide universal flu protection

Researchers at Janssen Pharmaceuticals Inc. and the Scripps Research Institute have created a prophylactic universal flu therapy by combining four llama antibodies into a single protein.

Most flu vaccines stimulate the generation of antibodies against the head domain of hemagglutinin (HA), an antigen known to rapidly mutate to escape antibody binding. ...